First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced CancersBranimir I. Šikić, Sukhmani K. Padda, Amita Patnaik et al.|Journal of Clinical Oncology|2019Cited by 590
Functional Network Analysis Reveals Extended Gliomagenesis Pathway Maps and Three Novel MYC-Interacting Genes in Human GliomasMarkus Bredel, Branimir I. Šikić|Cancer Research|2005Cited by 312
Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transitionGeorge E. Durán, Branimir I. Šikić|British Journal of Cancer|2017Cited by 47
The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistanceGeorge E. Durán, Branimir I. Šikić|PLoS ONE|2019Cited by 4